HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ann M Bode Selected Research

Resveratrol

12/2010Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene Aâ‚„hydrolase.
12/2008The resveratrol analogue 3,5,3',4',5'-pentahydroxy-trans-stilbene inhibits cell transformation via MEK.
10/2008Resveratrol directly targets COX-2 to inhibit carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ann M Bode Research Topics

Disease

192Neoplasms (Cancer)
01/2024 - 03/2002
70Carcinogenesis
09/2023 - 01/2003
32Skin Neoplasms (Skin Cancer)
11/2020 - 01/2003
23Colonic Neoplasms (Colon Cancer)
10/2023 - 10/2008
15Inflammation (Inflammations)
03/2020 - 05/2008
14Melanoma (Melanoma, Malignant)
05/2020 - 08/2005
13Neoplasm Metastasis (Metastasis)
10/2023 - 06/2007
13Nasopharyngeal Carcinoma
10/2023 - 11/2011
13Lung Neoplasms (Lung Cancer)
01/2021 - 05/2010
13Neoplastic Cell Transformation
03/2016 - 06/2004
12Breast Neoplasms (Breast Cancer)
10/2017 - 09/2006
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2019 - 06/2013
9Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 07/2007
7Leukemia
11/2019 - 06/2007
6Esophageal Squamous Cell Carcinoma
12/2019 - 01/2017
6Body Weight (Weight, Body)
01/2019 - 04/2008
5Esophageal Neoplasms (Esophageal Cancer)
11/2020 - 05/2016
5Infections
03/2020 - 12/2012
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2023 - 01/2017
4Obesity
03/2020 - 10/2008
4Urinary Bladder Neoplasms (Bladder Cancer)
09/2017 - 05/2011
4Pancreatic Neoplasms (Pancreatic Cancer)
12/2015 - 11/2010
3Papilloma (Papillomatosis)
11/2020 - 04/2009
3Stomach Neoplasms (Stomach Cancer)
03/2020 - 09/2018
3Carcinoma (Carcinomatosis)
01/2020 - 03/2016
3Pain (Aches)
03/2016 - 02/2009
3Prostatic Neoplasms (Prostate Cancer)
11/2015 - 07/2012

Drug/Important Bio-Agent (IBA)

55Proteins (Proteins, Gene)FDA Link
09/2022 - 06/2004
22Phosphotransferases (Kinase)IBA
08/2019 - 06/2004
17Protein Kinases (Protein Kinase)IBA
10/2023 - 01/2003
16CarcinogensIBA
12/2021 - 03/2002
14Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020 - 07/2007
13Biomarkers (Surrogate Marker)IBA
09/2023 - 04/2008
13Epidermal Growth Factor (EGF)IBA
09/2016 - 07/2005
11Histones (Histone)IBA
11/2019 - 07/2005
10Small Interfering RNA (siRNA)IBA
05/2020 - 06/2004
9Transcription Factors (Transcription Factor)IBA
09/2023 - 06/2006
9ErbB Receptors (EGF Receptor)IBA
02/2018 - 04/2008
9Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2018 - 07/2005
8FlavonoidsIBA
12/2019 - 12/2010
8AgarIBA
09/2016 - 01/2006
8PhytochemicalsIBA
04/2015 - 04/2010
7Membrane Proteins (Integral Membrane Proteins)IBA
10/2023 - 01/2013
7EnzymesIBA
11/2022 - 06/2006
7Gefitinib (Iressa)FDA Link
02/2018 - 04/2008
6Oncogene Proteins (Oncogene Protein)IBA
01/2022 - 04/2012
6DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2013
6TeaIBA
09/2014 - 03/2006
6Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2010 - 07/2008
5ProstaglandinsIBA
01/2022 - 10/2009
5AntioxidantsIBA
01/2020 - 07/2008
5Cyclin-Dependent Kinase Inhibitor p16IBA
06/2016 - 08/2005
5Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
12/2015 - 04/2008
4Capsaicin (Zostrix)FDA Link
03/2020 - 09/2010
4LipidsIBA
03/2020 - 07/2013
4Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
08/2019 - 04/2010
4daidzeinIBA
05/2017 - 11/2007
4IsoflavonesIBA
05/2017 - 11/2007
4Protein Isoforms (Isoforms)IBA
01/2017 - 03/2002
4Estrogen ReceptorsIBA
01/2017 - 08/2011
4Mitogen-Activated Protein KinasesIBA
05/2013 - 06/2006
4ArsenicIBA
09/2012 - 04/2002
4epigallocatechin gallate (epigallocatechin-3-gallate)IBA
09/2011 - 03/2008
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
06/2023 - 10/2009
3Fatty Acids (Saturated Fatty Acids)IBA
11/2022 - 01/2018
3PolyphenolsIBA
03/2020 - 12/2010
3Aurora Kinase BIBA
01/2020 - 01/2013
3Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2020 - 01/2017
3leukotriene A4 hydrolaseIBA
06/2019 - 07/2009
3Phosphatidylinositols (Phosphatidylinositol)IBA
01/2019 - 06/2013
3Glucose (Dextrose)FDA LinkGeneric
01/2019 - 09/2006
3Cyclin D1IBA
10/2018 - 03/2014
3Messenger RNA (mRNA)IBA
11/2017 - 09/2012
3CateninsIBA
11/2017 - 12/2013
3Therapeutic UsesIBA
10/2017 - 05/2016
3Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
10/2017 - 01/2016
3NitrosaminesIBA
09/2017 - 05/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 04/2010
3Immunoglobulins (Immunoglobulin)IBA
01/2016 - 11/2011
3Caspase 7IBA
11/2015 - 06/2011
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
09/2015 - 07/2012
3MicroRNAs (MicroRNA)IBA
06/2015 - 11/2012
3CaspasesIBA
02/2015 - 09/2006
3kaempferolIBA
09/2014 - 05/2009
3Adenosine Triphosphate (ATP)IBA
08/2014 - 09/2013
3Lapatinib (GW572016)FDA Link
01/2014 - 08/2011
3ResveratrolIBA
12/2010 - 10/2008
3myricetinIBA
05/2010 - 09/2007
3arseniteIBA
10/2009 - 11/2006
2N- (12- cyanoindolizino(2,3- b)quinoxalin- 2- yl)thiophene- 2- carboxamideIBA
10/2023 - 06/2012
2Cyclin-Dependent Kinases (cdk Proteins)IBA
06/2023 - 09/2013
2Estrogens (Estrogen)FDA Link
01/2023 - 01/2019
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2022 - 01/2017
2Urethane (Ethyl Carbamate)IBA
01/2021 - 01/2018
2WT1 ProteinsIBA
01/2021 - 12/2017

Therapy/Procedure

40Therapeutics
11/2023 - 07/2003
11Chemoprevention
01/2017 - 01/2003
9Drug Therapy (Chemotherapy)
02/2021 - 06/2006
6Radiotherapy
01/2024 - 06/2015
5Oral Administration
01/2019 - 11/2006